A multicentre, prospective, randomised study of the value of a single dose of intravesical Mitomycin-C in preventing the development of bladder tumours following nephroureterectomy for transitional cell carcinoma (TCC) of the upper urinary tract

ISRCTN ISRCTN36343644
DOI https://doi.org/10.1186/ISRCTN36343644
Secondary identifying numbers 0062/WASH/2000
Submission date
29/07/2005
Registration date
02/09/2005
Last edited
17/10/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

http://cancerhelp.cancerresearchuk.org/trials/a-trial-looking-at-giving-chemotherapy-into-the-bladder-after-surgery-for-kidney-cancer

Contact information

Mr Tim O'Brien
Scientific

Department of Urology
1st floor Thomas Guy House
Guy’'s Hospital
St Thomas’ Street
London
SE1 9RT
United Kingdom

Phone +44 (0)207 1886796
Email tim.obrien@gstt.nhs.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typePrevention
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleA multicentre, prospective, randomised study of the value of a single dose of intravesical Mitomycin-C in preventing the development of bladder tumours following nephroureterectomy for transitional cell carcinoma (TCC) of the upper urinary tract
Study acronymODMIT-C
Study objectivesThe hypothesis is that a single dose of intravesical Mitomycin-C prevents tumour recurrence in the bladder following nephroureterectomy for a transitional cell carcinoma of the upper urinary tract.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedUpper tract TCC bladder
InterventionIntravesical instillation of Mitomycin-C post operatively versus no Mitomycin-C
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Mitomycin-C
Primary outcome measureIncidence of tumour recurrence at 1 year post nephroureterectomy
Secondary outcome measuresTo study the post surgical survival of these patients over five years.
Overall study start date20/07/2000
Completion date01/12/2007

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants268
Key inclusion criteria1. A new clinical diagnosis of a transitional cell tumour of the upper urinary tract above the intramural ureter
2. A negative cystoscopy for TCC bladder within one month of the nephroureterectomy
3. A nephroureterectomy that is planned to be performed in such a way that there is early distal ligation of the ureter prior to the mobilisation of the tumour. The intramural portion of the ureter may be resected prior to the open part of the operation, taken at the open operation with a cuff of bladder or everted at the end of the operation and resected endoscopically according to surgical preference.
4. Have a life expectancy of at least one year
5. Informed consent to participate (written and witnessed)
Key exclusion criteria1. The histology of the upper tract tumour does not confirm a transitional cell carcinoma
2. Stage N1 or M1
3. Had additional systemic chemotherapy or additional intravesical Mitomycin-C at follow up cystoscopies
4. Existing or previous transitional cell carcinoma of bladder
5. Children, pregnant women excluded
6. Life expectancy less than one year
7. Known sensitivity to Mitomycin-C
Date of first enrolment20/07/2000
Date of final enrolment01/12/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Guy’'s Hospital
London
SE1 9RT
United Kingdom

Sponsor information

Sussex NHS Research Consortium (UK)
Government

Research Department
Worthing Hospital
Lyndhurst Road
Worthing
BN11 2DH
United Kingdom

Phone +44 (0)1903 285224
Email john.sitzia@wash.nhs.uk

Funders

Funder type

Charity

Guy's and St. Thomas' Charity (UK)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
Guy's and St Thomas' Charity, Guy's and St Thomas' Foundation, GSTTFoundation
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Plain English results No Yes
Results article results 01/10/2011 Yes No

Editorial Notes

17/10/2018: Cancer Research UK lay results summary link added to Results (plain English)